Reverse Transcriptase News and Research

RSS
No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

New test detects SARS-CoV-2 in less than 5 mins

New test detects SARS-CoV-2 in less than 5 mins

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Current testing-isolation policies effectively prevent campus transmission of COVID-19

Current testing-isolation policies effectively prevent campus transmission of COVID-19

Single N primer sufficient for SARS-CoV-2 molecular diagnosis

Single N primer sufficient for SARS-CoV-2 molecular diagnosis

Paper-based electrochemical sensor can enable rapid detection of SARS-CoV-2

Paper-based electrochemical sensor can enable rapid detection of SARS-CoV-2

STE90-C11, a SARS-CoV-2 neutralizing antibody, shows high inhibition of RBD-ACE2 binding

STE90-C11, a SARS-CoV-2 neutralizing antibody, shows high inhibition of RBD-ACE2 binding

COVID-19 single-shot segmentation for chest CT-based diagnosis

COVID-19 single-shot segmentation for chest CT-based diagnosis

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

Chinese woman still sheds SARS-CoV-2 over four months post-infection

Chinese woman still sheds SARS-CoV-2 over four months post-infection

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Antihypertensive drugs may reduce COVID-19 mortality in at-risk patients

Antihypertensive drugs may reduce COVID-19 mortality in at-risk patients

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Early high-titer convalescent plasma prevents 75% of severe COVID-19 in elderly

Early high-titer convalescent plasma prevents 75% of severe COVID-19 in elderly

Mildly symptomatic COVID-19 patients may be contagious for longer than previously thought

Mildly symptomatic COVID-19 patients may be contagious for longer than previously thought

Repeat infection following COVID-19 recovery may not pose risk to close contacts

Repeat infection following COVID-19 recovery may not pose risk to close contacts